2014 - Fellow of the American Psychological Association (APA)
Amy J. Jak mainly focuses on Neuropsychology, Cognition, Psychiatry, Brain mapping and Neuroscience. Her Neuropsychology study combines topics in areas such as Lesion, Analysis of variance, Dementia, Clinical psychology and Apolipoprotein E. Her biological study deals with issues like Oncology, which deal with fields such as Internal medicine, Cognitive test, Biomarker, Neuroimaging and Discriminant function analysis.
Her work in Cognition covers topics such as Disease which are related to areas like Cohort. While the research belongs to areas of Brain mapping, she spends her time largely on the problem of Twin study, intersecting her research to questions surrounding Cerebral cortex and Cortical surface. Her Cognitive impairment study incorporates themes from Cross-sectional study, Longitudinal study, Psychometrics and Medical diagnosis.
Amy J. Jak mostly deals with Neuropsychology, Cognition, Clinical psychology, Traumatic brain injury and Internal medicine. The concepts of her Neuropsychology study are interwoven with issues in Disease, Cognitive impairment, Audiology, Neuroimaging and Biomarker. Her Cognition research integrates issues from Developmental psychology, Incidence and Association.
Her research in Clinical psychology focuses on subjects like Depression, which are connected to Executive dysfunction. Her Traumatic brain injury study results in a more complete grasp of Psychiatry. Her Internal medicine research is multidisciplinary, relying on both Endocrinology, Neuroscience and Cardiology.
Her main research concerns Neuropsychology, Clinical psychology, Traumatic brain injury, Cognition and Disease. Amy J. Jak performs integrative study on Neuropsychology and Unemployment. Her Clinical psychology research is multidisciplinary, incorporating perspectives in Cognitive skill, Mental health and Depression.
Her Cognition study frequently links to related topics such as Cognitive psychology. Amy J. Jak studies Disease, focusing on Cognitive impairment in particular. Her research investigates the connection between Cognitive impairment and topics such as Neuroimaging that intersect with issues in Internal medicine, Cognitive test, Medical diagnosis, Incidence and Sample size determination.
The scientist’s investigation covers issues in Neuropsychology, Traumatic brain injury, Clinical psychology, Cognition and Neuroimaging. She combines topics linked to Biomarker with her work on Neuropsychology. Her research integrates issues of Cognitive skill and Depression in her study of Clinical psychology.
Her biological study spans a wide range of topics, including Intervention and Posttraumatic stress. Her Neuroimaging research incorporates themes from Alzheimer's Disease Neuroimaging Initiative and Cognitive impairment. Her work carried out in the field of Cognitive impairment brings together such families of science as Apolipoprotein E and Dementia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quantification of five neuropsychological approaches to defining mild cognitive impairment.
Amy J. Jak;Amy J. Jak;Mark W. Bondi;Mark W. Bondi;Lisa Delano-Wood;Christina Wierenga;Christina Wierenga.
American Journal of Geriatric Psychiatry (2009)
Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates
Mark W. Bondi;Emily C. Edmonds;Amy J. Jak;Lindsay R. Clark.
Journal of Alzheimer's Disease (2014)
Hierarchical Genetic Organization of Human Cortical Surface Area
Chi-Hua Chen;E. D. Gutierrez;Wes Thompson;Matthew S. Panizzon.
Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease
Mark W. Bondi;Mark W. Bondi;Amy J. Jak;Lisa Delano-Wood;Mark W. Jacobson.
Neuropsychology Review (2008)
Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions.
Marilyn Huckans;Lee Hutson;Elizabeth Twamley;Elizabeth Twamley;Amy Jak.
Neuropsychology Review (2013)
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Jeffrey A. Cohen;Gary R. Cutter;Jill S. Fischer;Andrew D. Goodman.
JAMA Neurology (2001)
Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors
Emily C. Edmonds;Lisa Delano-Wood;Lisa Delano-Wood;Lindsay R. Clark;Amy J. Jak;Amy J. Jak.
Alzheimers & Dementia (2015)
Intrarater and interrater reliability of the MS functional composite outcome measure.
Jeffrey A. Cohen;J. S. Fischer;D. M. Bolibrush;A. J. Jak.
Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response
S. Duke Han;Wes S. Houston;Amy J. Jak;Lisa T. Eyler;Lisa T. Eyler.
Neurobiology of Aging (2007)
Heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology
Lisa Delano-Wood;Mark W. Bondi;Joshua Sacco;Norm Abeles.
Journal of The International Neuropsychological Society (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: